{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T04:02:27Z","timestamp":1788580947287,"version":"build-2803163510"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Neurosci"],"DOI":"10.1007\/s12031-026-02497-x","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T08:25:20Z","timestamp":1772439920000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Lower Plasma Serotonin is Associated with Higher Amyloid Burden, Hippocampal Atrophy, and Cognitive decline in Alzheimer\u2019s Disease: A 24-Month Longitudinal Study"],"prefix":"10.1007","volume":"76","author":[{"given":"Yingbo","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hehua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9388-9261","authenticated-orcid":false,"given":"Wenchao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"For the Alzheimer\u2019s Disease Neuroimaging Initiative","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,2]]},"reference":[{"key":"2497_CR1","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.bbr.2014.07.038","volume":"277","author":"N Alenina","year":"2015","unstructured":"Alenina N, Klempin F (2015) The role of serotonin in adult hippocampal neurogenesis. Behav Brain Res 277:49\u201357. https:\/\/doi.org\/10.1016\/j.bbr.2014.07.038","journal-title":"Behav Brain Res"},{"key":"2497_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.metop.2025.100389","author":"F Alzenaidi","year":"2025","unstructured":"Alzenaidi F, Aldoweesh O, Alghofaili S, Fadel A, Lasloom RAA, Alharbi D et al (2025) Selective serotonin reuptake inhibitors and glucose metabolism in Alzheimer\u2019s disease and related dementias: a systematic review and meta-analysis of brain metabolic and adverse event data. Metab Open. https:\/\/doi.org\/10.1016\/j.metop.2025.100389","journal-title":"Metab Open"},{"issue":"1","key":"2497_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s13041-024-01118-1","volume":"17","author":"A Azargoonjahromi","year":"2024","unstructured":"Azargoonjahromi A (2024a) The duality of amyloid-\u03b2: its role in normal and Alzheimer\u2019s disease states. Mol Brain 17(1):44. https:\/\/doi.org\/10.1186\/s13041-024-01118-1","journal-title":"Mol Brain"},{"issue":"1","key":"2497_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s13041-024-01169-4","volume":"17","author":"A Azargoonjahromi","year":"2024","unstructured":"Azargoonjahromi A (2024b) Serotonin enhances neurogenesis biomarkers, hippocampal volumes, and cognitive functions in Alzheimer\u2019s disease. Mol Brain 17(1):93. https:\/\/doi.org\/10.1186\/s13041-024-01169-4","journal-title":"Mol Brain"},{"issue":"2","key":"2497_CR5","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s11682-025-00992-0","volume":"19","author":"A Azargoonjahromi","year":"2025","unstructured":"Azargoonjahromi A (2025) Plasma tryptophan levels are linked to hippocampal integrity and cognitive function in individuals with mild cognitive impairment. Brain Imaging Behav 19(2):485\u2013496. https:\/\/doi.org\/10.1007\/s11682-025-00992-0","journal-title":"Brain Imaging Behav"},{"issue":"1","key":"2497_CR6","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13041-024-01169-4","volume":"17","author":"A Azargoonjahromi","year":"2024","unstructured":"Azargoonjahromi A, Initiative ADN (2024) Serotonin enhances neurogenesis biomarkers, hippocampal volumes, and cognitive functions in Alzheimer\u2019s disease. Mol Brain 17(1):93","journal-title":"Mol Brain"},{"issue":"6","key":"2497_CR7","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.ijdevneu.2007.06.003","volume":"25","author":"X Borue","year":"2007","unstructured":"Borue X, Chen J, Condron BG (2007) Developmental effects of ssris: lessons learned from animal studies. Int J Dev Neurosci 25(6):341\u2013347. https:\/\/doi.org\/10.1016\/j.ijdevneu.2007.06.003","journal-title":"Int J Dev Neurosci"},{"key":"2497_CR8","first-page":"91","volume":"1","author":"M Butzlaff","year":"2016","unstructured":"Butzlaff M, Ponimaskin E (2016) The role of serotonin receptors in Alzheimer\u2019s disease. Oper Med Physiol 1:91\u2013100","journal-title":"Oper Med Physiol"},{"key":"2497_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fnint.2013.00025","author":"P Celada","year":"2013","unstructured":"Celada P, Puig MV, Artigas F (2013) Serotonin modulation of cortical neurons and networks. Front Integr Neurosci. https:\/\/doi.org\/10.3389\/fnint.2013.00025","journal-title":"Front Integr Neurosci"},{"key":"2497_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2025.1552145","author":"A Chai","year":"2025","unstructured":"Chai A (2025) Pleiotropic neurotransmitters: neurotransmitter-receptor crosstalk regulates excitation-inhibition balance in social brain functions and pathologies. Front Neurosci. https:\/\/doi.org\/10.3389\/fnins.2025.1552145","journal-title":"Front Neurosci"},{"key":"2497_CR11","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.neulet.2019.03.050","volume":"704","author":"S Chakraborty","year":"2019","unstructured":"Chakraborty S, Lennon JC, Malkaram SA, Zeng Y, Fisher DW, Dong H (2019) Serotonergic system, cognition, and BPSD in Alzheimer\u2019s disease. Neurosci Lett 704:36\u201344","journal-title":"Neurosci Lett"},{"issue":"4","key":"2497_CR12","doi-asserted-by":"publisher","first-page":"560","DOI":"10.2967\/jnumed.114.149732","volume":"56","author":"K Chen","year":"2015","unstructured":"Chen K, Roontiva A, Thiyyagura P, Lee W, Liu X, Ayutyanont N et al (2015) Improved power for characterizing longitudinal amyloid-\u03b2 PET changes and evaluating amyloid-modifying treatments with a cerebral white matter reference region. J Nucl Med 56(4):560\u20136. https:\/\/doi.org\/10.2967\/jnumed.114.149732","journal-title":"J Nucl Med"},{"issue":"1","key":"2497_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-024-00425-w","volume":"13","author":"M Chen","year":"2024","unstructured":"Chen M, Wang C, Lin Y, Chen Y, Xie W, Huang X et al (2024) Dorsal raphe nucleus-hippocampus serotonergic circuit underlies the depressive and cognitive impairments in 5\u00d7FAD male mice. Transl Neurodegener 13(1):34. https:\/\/doi.org\/10.1186\/s40035-024-00425-w","journal-title":"Transl Neurodegener"},{"issue":"5","key":"2497_CR14","first-page":"627","volume":"3","author":"TW Chow","year":"2007","unstructured":"Chow TW, Pollock BG, Milgram NW (2007) Potential cognitive enhancing and disease modification effects of SSRIs for Alzheimer\u2019s disease. Neuropsychiatr Dis Treat 3(5):627\u2013636","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"36","key":"2497_CR15","doi-asserted-by":"publisher","first-page":"14968","DOI":"10.1073\/pnas.1107411108","volume":"108","author":"JR Cirrito","year":"2011","unstructured":"Cirrito JR, Disabato BM, Restivo JL, Verges DK, Goebel WD, Sathyan A et al (2011) Serotonin signaling is associated with lower amyloid-\u03b2 levels and plaques in transgenic mice and humans. Proc Natl Acad Sci U S A 108(36):14968\u201373. https:\/\/doi.org\/10.1073\/pnas.1107411108","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"19","key":"2497_CR16","doi-asserted-by":"publisher","first-page":"e2666","DOI":"10.1212\/wnl.0000000000010733","volume":"95","author":"JR Cirrito","year":"2020","unstructured":"Cirrito JR, Wallace CE, Yan P, Davis TA, Gardiner WD, Doherty BM et al (2020) Effect of escitalopram on A\u03b2 levels and plaque load in an Alzheimer mouse model. Neurology 95(19):e2666\u2013e74. https:\/\/doi.org\/10.1212\/wnl.0000000000010733","journal-title":"Neurology"},{"issue":"1","key":"2497_CR17","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1021\/cn300095t","volume":"4","author":"M Cochet","year":"2013","unstructured":"Cochet M, Donneger R, Cassier E, Gaven F, Lichtenthaler SF, Marin P et al (2013) 5-HT4 receptors constitutively promote the non-amyloidogenic pathway of APP cleavage and interact with ADAM10. ACS Chem Neurosci 4(1):130\u201340. https:\/\/doi.org\/10.1021\/cn300095t","journal-title":"ACS Chem Neurosci"},{"issue":"2","key":"2497_CR18","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1017\/s1092852915000425","volume":"21","author":"E Dale","year":"2016","unstructured":"Dale E, Pehrson AL, Jeyarajah T, Li Y, Leiser SC, Smagin G et al (2016) Effects of serotonin in the hippocampus: how SSRIs and multimodal antidepressants might regulate pyramidal cell function. CNS Spectr 21(2):143\u201361. https:\/\/doi.org\/10.1017\/s1092852915000425","journal-title":"CNS Spectr"},{"issue":"1","key":"2497_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-024-01567-9","volume":"16","author":"V Dauphinot","year":"2024","unstructured":"Dauphinot V, Calvi S, Moutet C, Xie J, Dautricourt S, Batsavanis A et al (2024) Reliability of the assessment of the clinical dementia rating scale from the analysis of medical records in comparison with the reference method. Alzheimers Res Ther 16(1):198. https:\/\/doi.org\/10.1186\/s13195-024-01567-9","journal-title":"Alzheimers Res Ther"},{"key":"2497_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26115218","author":"LP Dolgacheva","year":"2025","unstructured":"Dolgacheva LP, Zinchenko VP, Nadeev AD, Goncharov NV (2025) Serotonergic regulation in Alzheimer\u2019s disease. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms26115218","journal-title":"Int J Mol Sci"},{"issue":"11","key":"2497_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26115218","volume":"26","author":"LP Dolgacheva","year":"2025","unstructured":"Dolgacheva LP, Zinchenko VP, Nadeev AD, Goncharov NV (2025) Serotonergic regulation in Alzheimer\u2019s disease. Int J Mol Sci 26(11):5218","journal-title":"Int J Mol Sci"},{"issue":"5","key":"2497_CR22","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/nan.12387","volume":"43","author":"AJ Ehrenberg","year":"2017","unstructured":"Ehrenberg AJ, Nguy AK, Theofilas P, Dunlop S, Suemoto CK, Di Lorenzo Alho AT et al (2017) Quantifying the accretion of hyperphosphorylated tau in the locus coeruleus and dorsal raphe nucleus: the pathological building blocks of early Alzheimer\u2019s disease. Neuropathol Appl Neurobiol 43(5):393\u2013408. https:\/\/doi.org\/10.1111\/nan.12387","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"3","key":"2497_CR23","first-page":"286","volume":"45","author":"BS Fernandes","year":"2023","unstructured":"Fernandes BS, Inam ME, Enduru N, Quevedo J, Zhao Z (2023) The kynurenine pathway in Alzheimer\u2019s disease: a meta-analysis of central and peripheral levels. Braz J Psychiatry 45(3):286\u2013297","journal-title":"Braz J Psychiatry"},{"key":"2497_CR24","doi-asserted-by":"publisher","unstructured":"Giannoni P, Gaven F, De Bundel D, Baranger K, Marchetti-Gauthier E, Roman FS et al (2013) Early administration of RS 67333, a specific 5-HT4 receptor agonist, prevents amyloidogenesis and behavioral deficits in the 5XFAD mouse model of alzheimer\u2019s disease. Front Aging Neurosci 5\u20132013. https:\/\/doi.org\/10.3389\/fnagi.2013.00096","DOI":"10.3389\/fnagi.2013.00096"},{"issue":"1","key":"2497_CR25","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/jnr.23126","volume":"91","author":"T Hochstrasser","year":"2013","unstructured":"Hochstrasser T, Hohsfield LA, Sperner-Unterweger B, Humpel C (2013) \u03b2\u2010amyloid induced effects on cholinergic, serotonergic, and dopaminergic neurons is differentially counteracted by anti\u2010inflammatory drugs. J Neurosci Res 91(1):83\u201394","journal-title":"J Neurosci Res"},{"key":"2497_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2021.101362","volume":"69","author":"T-W Hsu","year":"2021","unstructured":"Hsu T-W, Stubbs B, Liang C-S, Chen T-Y, Yeh T-C, Pan C-C et al (2021) Efficacy of serotonergic antidepressant treatment for the neuropsychiatric symptoms and agitation in dementia: a systematic review and meta-analysis. Ageing Res Rev 69:101362","journal-title":"Ageing Res Rev"},{"issue":"5","key":"2497_CR27","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1021\/acschemneuro.3c00626","volume":"15","author":"NS Khan","year":"2024","unstructured":"Khan NS, Uribe Isaza J, Rouhi N, Jamani NF, Jabeen S, Gill AK et al (2024) Behavioral and neurophysiological implications of pathological human tau expression in serotonin neurons. ACS Chem Neurosci 15(5):932\u201343. https:\/\/doi.org\/10.1021\/acschemneuro.3c00626","journal-title":"ACS Chem Neurosci"},{"issue":"1","key":"2497_CR28","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000119205","volume":"32","author":"AM Kumar","year":"1995","unstructured":"Kumar AM, Sevush S, Kumar M, Ruiz J, Eisdorfer C (1995) Peripheral serotonin in Alzheimer\u2019s disease. Neuropsychobiology 32(1):9\u201312. https:\/\/doi.org\/10.1159\/000119205","journal-title":"Neuropsychobiology"},{"key":"2497_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2022.102333","volume":"217","author":"J Leschik","year":"2022","unstructured":"Leschik J, Gentile A, Cicek C, P\u00e9ron S, Tevosian M, Beer A et al (2022) Brain-derived neurotrophic factor expression in serotonergic neurons improves stress resilience and promotes adult hippocampal neurogenesis. Prog Neurobiol 217:102333. https:\/\/doi.org\/10.1016\/j.pneurobio.2022.102333","journal-title":"Prog Neurobiol"},{"issue":"1\u20132","key":"2497_CR30","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/s0531-5565(02)00157-2","volume":"38","author":"F Lezoualc'h","year":"2003","unstructured":"Lezoualc\u2019h F, Robert SJ (2003) The serotonin 5-HT4 receptor and the amyloid precursor protein processing. Exp Gerontol 38(1\u20132):159\u201366. https:\/\/doi.org\/10.1016\/s0531-5565(02)00157-2","journal-title":"Exp Gerontol"},{"issue":"11","key":"2497_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70946","volume":"21","author":"Y Li","year":"2025","unstructured":"Li Y, Liu W, Wang X, Qin W, Liu Z, Lyu D et al (2025) Effect of SSRIs on clinical progression in amnestic mild cognitive impairment stratified by Alzheimer\u2019s disease pathology. Alzheimers Dement 21(11):e70946. https:\/\/doi.org\/10.1002\/alz.70946","journal-title":"Alzheimers Dement"},{"issue":"24","key":"2497_CR32","doi-asserted-by":"publisher","first-page":"6804","DOI":"10.1016\/j.cell.2024.09.041","volume":"187","author":"Y Li","year":"2024","unstructured":"Li Y, Briguglio JJ, Romani S, Magee JC (2024) Mechanisms of memory-supporting neuronal dynamics in hippocampal area CA3. Cell 187(24):6804\u201319.e21. https:\/\/doi.org\/10.1016\/j.cell.2024.09.041","journal-title":"Cell"},{"issue":"1","key":"2497_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-017-0298-y","volume":"9","author":"CU von Linstow","year":"2017","unstructured":"von Linstow CU, Waider J, Grebing M, Metaxas A, Lesch KP, Finsen B (2017) Serotonin augmentation therapy by escitalopram has minimal effects on amyloid-\u03b2 levels in early-stage Alzheimer\u2019s-like disease in mice. Alzheimers Res Ther 9(1):74. https:\/\/doi.org\/10.1186\/s13195-017-0298-y","journal-title":"Alzheimers Res Ther"},{"issue":"7","key":"2497_CR34","doi-asserted-by":"publisher","first-page":"4539","DOI":"10.1007\/s12035-015-9388-7","volume":"53","author":"Y Liu","year":"2016","unstructured":"Liu Y, Tan L, Wang H-F, Liu Y, Hao X-K, Tan C-C et al (2016) Multiple effect of APOE genotype on clinical and neuroimaging biomarkers across Alzheimer\u2019s disease spectrum. Mol Neurobiol 53(7):4539\u201347","journal-title":"Mol Neurobiol"},{"issue":"2","key":"2497_CR35","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","volume":"179","author":"JM Long","year":"2019","unstructured":"Long JM, Holtzman DM (2019) Alzheimer disease: an update on pathobiology and treatment strategies. Cell 179(2):312\u2013339. https:\/\/doi.org\/10.1016\/j.cell.2019.09.001","journal-title":"Cell"},{"issue":"1","key":"2497_CR36","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4103\/1673-5374.264445","volume":"15","author":"B Mdawar","year":"2020","unstructured":"Mdawar B, Ghossoub E, Khoury R (2020) Selective serotonin reuptake inhibitors and Alzheimer\u2019s disease. Neural Regen Res 15(1):41\u201346","journal-title":"Neural Regen Res"},{"issue":"1","key":"2497_CR37","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13195-019-0491-2","volume":"11","author":"A Metaxas","year":"2019","unstructured":"Metaxas A, Anzalone M, Vaitheeswaran R, Petersen S, Landau AM, Finsen B (2019) Neuroinflammation and amyloid-beta 40 are associated with reduced serotonin transporter (SERT) activity in a transgenic model of familial alzheimer\u2019s disease. Alzheimers Res Ther 11(1):38","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"2497_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-019-0491-2","volume":"11","author":"A Metaxas","year":"2019","unstructured":"Metaxas A, Anzalone M, Vaitheeswaran R, Petersen S, Landau AM, Finsen B (2019) Neuroinflammation and amyloid-beta 40 are associated with reduced serotonin transporter (SERT) activity in a transgenic model of familial Alzheimer\u2019s disease. Alzheimers Res Ther 11(1):38. https:\/\/doi.org\/10.1186\/s13195-019-0491-2","journal-title":"Alzheimers Res Ther"},{"key":"2497_CR39","doi-asserted-by":"crossref","unstructured":"Arevalo-Rodriguez I, Smailagic N, Roqu\u00e9-Figuls M, Ciapponi A, Sanchez-Perez E, Giannakou A et al (2021) Mini-Mental state examination (MMSE) for the early detection of dementia in people with mild cognitive impairment (MCI). Cochrane Database Syst Rev (7)","DOI":"10.1002\/14651858.CD010783.pub3"},{"issue":"2","key":"2497_CR40","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1017\/S1041610296002578","volume":"8","author":"RC Mohs","year":"1996","unstructured":"Mohs RC (1996) The alzheimer\u2019s disease assessment scale. Int Psychogeriatr 8(2):195\u2013203","journal-title":"Int Psychogeriatr"},{"issue":"3","key":"2497_CR41","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/da.22584","volume":"34","author":"J Moraros","year":"2017","unstructured":"Moraros J, Nwankwo C, Patten SB, Mousseau DD (2017) The association of antidepressant drug usage with cognitive impairment or dementia, including Alzheimer disease: a systematic review and meta-analysis. Depress Anxiety 34(3):217\u2013226","journal-title":"Depress Anxiety"},{"issue":"7","key":"2497_CR42","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/S0006-3223(03)00174-4","volume":"54","author":"GM Murphy Jr","year":"2003","unstructured":"Murphy GM Jr, Kremer C, Rodrigues H, Schatzberg AF, Group MvPS (2003) The Apolipoprotein E \u03b54 allele and antidepressant efficacy in cognitively intact elderly depressed patients. Biol Psychiatry 54(7):665\u2013673","journal-title":"Biol Psychiatry"},{"issue":"2","key":"2497_CR43","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/nrneurol.2013.4","volume":"9","author":"New role for sortilin in amyloid processing","year":"2013","unstructured":"New role for sortilin in amyloid processing (2013) Nat Reviews Neurol 9(2):62. https:\/\/doi.org\/10.1038\/nrneurol.2013.4","journal-title":"Nat Reviews Neurol"},{"key":"2497_CR44","doi-asserted-by":"publisher","DOI":"10.20344\/amp.8859","author":"J Nogueira","year":"2018","unstructured":"Nogueira J, Freitas S, Duro D, Tabuas-Pereira M, Guerreiro M, Almeida J et al (2018) Alzheimer\u2019s Disease Assessment Scale-Cognitive Subscale (ADAS-Cog): normative data for the Portuguese population. Acta Med Port. https:\/\/doi.org\/10.20344\/amp.8859","journal-title":"Acta Med Port"},{"issue":"8","key":"2497_CR45","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1001\/archneur.65.8.1091","volume":"65","author":"SE O\u2019Bryant","year":"2008","unstructured":"O\u2019Bryant SE, Waring SC, Cullum CM, Hall J, Lacritz L, Massman PJ et al (2008) Staging dementia using clinical dementia rating scale sum of boxes scores: a Texas alzheimer\u2019s research consortium study. Arch Neurol 65(8):1091\u20131095. https:\/\/doi.org\/10.1001\/archneur.65.8.1091","journal-title":"Arch Neurol"},{"issue":"2","key":"2497_CR46","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/s41380-024-02664-9","volume":"30","author":"SR Pierson","year":"2025","unstructured":"Pierson SR, Fiock KL, Wang R, Balasubramanian N, Reinhardt J, Khan KM et al (2025) Tau pathology in the dorsal raphe may be a prodromal indicator of Alzheimer\u2019s disease. Mol Psychiatry 30(2):532\u2013546. https:\/\/doi.org\/10.1038\/s41380-024-02664-9","journal-title":"Mol Psychiatry"},{"key":"2497_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107171","volume":"203","author":"SR Pierson","year":"2024","unstructured":"Pierson SR, Kolling LJ, James TD, Pushpavathi SG, Marcinkiewcz CA (2024) Serotonergic dysfunction may mediate the relationship between alcohol consumption and Alzheimer\u2019s disease. Pharmacol Res 203:107171. https:\/\/doi.org\/10.1016\/j.phrs.2024.107171","journal-title":"Pharmacol Res"},{"issue":"4","key":"2497_CR48","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.ajpath.2016.12.010","volume":"187","author":"N Postupna","year":"2017","unstructured":"Postupna N, Latimer CS, Larson EB, Sherfield E, Paladin J, Shively CA et al (2017) Human striatal dopaminergic and regional serotonergic synaptic degeneration with Lewy body disease and inheritance of APOE \u03b54. Am J Pathol 187(4):884\u201395","journal-title":"Am J Pathol"},{"issue":"4","key":"2497_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2013.30","volume":"3","author":"G Quesseveur","year":"2013","unstructured":"Quesseveur G, David DJ, Gaillard MC, Pla P, Wu MV, Nguyen HT et al (2013) BDNF overexpression in mouse hippocampal astrocytes promotes local neurogenesis and elicits anxiolytic-like activities. Transl Psychiatry 3(4):e253. https:\/\/doi.org\/10.1038\/tp.2013.30","journal-title":"Transl Psychiatry"},{"key":"2497_CR50","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.mcn.2017.09.009","volume":"85","author":"PS Rojas","year":"2017","unstructured":"Rojas PS, Aguayo F, Neira D, Tejos M, Aliaga E, Mu\u00f1oz JP et al (2017) Dual effect of serotonin on the dendritic growth of cultured hippocampal neurons: involvement of 5-HT(1A) and 5-HT(7) receptors. Mol Cell Neurosci 85:148\u201361. https:\/\/doi.org\/10.1016\/j.mcn.2017.09.009","journal-title":"Mol Cell Neurosci"},{"key":"2497_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12122744","author":"GU Rosas-S\u00e1nchez","year":"2024","unstructured":"Rosas-S\u00e1nchez GU, Germ\u00e1n-Ponciano LJ, Guillen-Ruiz G, Cueto-Escobedo J, Lim\u00f3n-V\u00e1zquez AK, Rodr\u00edguez-Landa JF et al (2024) Neuroplasticity and mechanisms of action of acute and chronic treatment with antidepressants in preclinical studies. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines12122744","journal-title":"Biomedicines"},{"issue":"2","key":"2497_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2023.166942","volume":"1870","author":"N Sawant","year":"2024","unstructured":"Sawant N, Kshirsagar S, Reddy PH, Reddy AP (2024) Protective effects of SSRI, Citalopram in mutant APP and mutant Tau expressed dorsal raphe neurons in Alzheimer\u2019s disease. Biochim Biophys Acta Mol Basis Dis 1870(2):166942. https:\/\/doi.org\/10.1016\/j.bbadis.2023.166942","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"2497_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2017.00142","volume":"11","author":"E Segi-Nishida","year":"2017","unstructured":"Segi-Nishida E (2017) The effect of serotonin-targeting antidepressants on neurogenesis and neuronal maturation of the hippocampus mediated via 5-HT1A and 5-HT4 receptors. Front Cell Neurosci 11:142. https:\/\/doi.org\/10.3389\/fncel.2017.00142","journal-title":"Front Cell Neurosci"},{"key":"2497_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2017.00142","author":"E Segi-Nishida","year":"2017","unstructured":"Segi-Nishida E (2017) The effect of serotonin-targeting antidepressants on neurogenesis and neuronal maturation of the hippocampus mediated via 5-HT1A and 5-HT4 receptors. Front Cell Neurosci. https:\/\/doi.org\/10.3389\/fncel.2017.00142","journal-title":"Front Cell Neurosci"},{"issue":"10","key":"2497_CR55","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s40266-012-0012-5","volume":"29","author":"AA Sepehry","year":"2012","unstructured":"Sepehry AA, Lee PE, Hsiung GYR, Beattie BL, Jacova C (2012) Effect of selective serotonin reuptake inhibitors in Alzheimer\u2019s disease with comorbid depression: a meta-analysis of depression and cognitive outcomes. Drugs Aging 29(10):793\u2013806","journal-title":"Drugs Aging"},{"issue":"236","key":"2497_CR56","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3008169","volume":"6","author":"YI Sheline","year":"2014","unstructured":"Sheline YI, West T, Yarasheski K, Swarm R, Jasielec MS, Fisher JR et al (2014) An antidepressant decreases CSF A\u03b2 production in healthy individuals and in transgenic AD mice. Sci Transl Med 6(236):236re4. https:\/\/doi.org\/10.1126\/scitranslmed.3008169","journal-title":"Sci Transl Med"},{"key":"2497_CR57","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.nbd.2017.05.007","volume":"105","author":"GS Smith","year":"2017","unstructured":"Smith GS, Barrett FS, Joo JH, Nassery N, Savonenko A, Sodums DJ et al (2017) Molecular imaging of serotonin degeneration in mild cognitive impairment. Neurobiol Dis 105:33\u201341. https:\/\/doi.org\/10.1016\/j.nbd.2017.05.007","journal-title":"Neurobiol Dis"},{"key":"2497_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2017.00185","author":"N-N Song","year":"2017","unstructured":"Song N-N, Huang Y, Yu X, Lang B, Ding Y-Q, Zhang L (2017) Divergent roles of central serotonin in adult hippocampal neurogenesis. Front Cell Neurosci. https:\/\/doi.org\/10.3389\/fncel.2017.00185","journal-title":"Front Cell Neurosci"},{"issue":"2","key":"2497_CR59","doi-asserted-by":"publisher","first-page":"621","DOI":"10.3233\/jad-160022","volume":"53","author":"W Tajeddinn","year":"2016","unstructured":"Tajeddinn W, Fereshtehnejad SM, Seed Ahmed M, Yoshitake T, Kehr J, Shahnaz T et al (2016) Association of platelet serotonin levels in Alzheimer\u2019s disease with clinical and cerebrospinal fluid markers. J Alzheimers Dis 53(2):621\u201330. https:\/\/doi.org\/10.3233\/jad-160022","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"2497_CR60","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.neuron.2018.04.030","volume":"98","author":"CM Teixeira","year":"2018","unstructured":"Teixeira CM, Rosen ZB, Suri D, Sun Q, Hersh M, Sargin D et al (2018) Hippocampal 5-HT input regulates memory formation and Schaffer collateral excitation. Neuron 98(5):992\u20131004e4. https:\/\/doi.org\/10.1016\/j.neuron.2018.04.030","journal-title":"Neuron"},{"issue":"8","key":"2497_CR61","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1097\/00001756-199505300-00033","volume":"6","author":"SM Tejani-Butt","year":"1995","unstructured":"Tejani-Butt SM, Yang J, Pawlyk AC (1995) Altered serotonin transporter sites in Alzheimer\u2019s disease raphe and hippocampus. Neuroreport 6(8):1207\u20131210. https:\/\/doi.org\/10.1097\/00001756-199505300-00033","journal-title":"Neuroreport"},{"issue":"21","key":"2497_CR62","doi-asserted-by":"publisher","first-page":"3800","DOI":"10.1021\/acschemneuro.4c00339","volume":"15","author":"R Tenchov","year":"2024","unstructured":"Tenchov R, Sasso JM, Zhou QA (2024) Alzheimer\u2019s disease: exploring the landscape of cognitive decline. ACS Chem Neurosci 15(21):3800\u20133827. https:\/\/doi.org\/10.1021\/acschemneuro.4c00339","journal-title":"ACS Chem Neurosci"},{"issue":"2","key":"2497_CR63","doi-asserted-by":"publisher","first-page":"e14579","DOI":"10.1002\/alz.14579","volume":"21","author":"DJ Terstege","year":"2025","unstructured":"Terstege DJ, Jabeen S, Initiative AsDN, Galea LA, Epp JR, Sargin D (2025) SSRIs reduce plasma tau and restore dorsal raphe metabolism in Alzheimer\u2019s disease. Alzheimers Dement 21(2):e14579","journal-title":"Alzheimers Dement"},{"issue":"2","key":"2497_CR64","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14579","volume":"21","author":"DJ Terstege","year":"2025","unstructured":"Terstege DJ, Jabeen S, Galea LAM, Epp JR, Sargin D (2025) SSRIs reduce plasma tau and restore dorsal raphe metabolism in Alzheimer\u2019s disease. Alzheimers Dement 21(2):e14579. https:\/\/doi.org\/10.1002\/alz.14579","journal-title":"Alzheimers Dement"},{"issue":"9","key":"2497_CR65","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1111\/j.1532-5415.1992.tb01992.x","volume":"40","author":"TN Tombaugh","year":"1992","unstructured":"Tombaugh TN, McIntyre NJ (1992) The mini-mental state examination: a comprehensive review. J Am Geriatr Soc 40(9):922\u2013935","journal-title":"J Am Geriatr Soc"},{"key":"2497_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/2051-5960-2-65","volume":"2","author":"M Veitinger","year":"2014","unstructured":"Veitinger M, Varga B, Guterres SB, Zellner M (2014) Platelets, a reliable source for peripheral Alzheimer\u2019s disease biomarkers? Acta Neuropathol Commun 2:65. https:\/\/doi.org\/10.1186\/2051-5960-2-65","journal-title":"Acta Neuropathol Commun"},{"key":"2497_CR67","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.neurobiolaging.2022.09.007","volume":"121","author":"X Wang","year":"2023","unstructured":"Wang X, Hu M, Xie Q, Geng C, Jin C, Ren W et al (2023) Amyloid \u03b2 oligomers disrupt piriform cortical output via a serotonergic pathway. Neurobiol Aging 121:64\u201377","journal-title":"Neurobiol Aging"},{"issue":"6","key":"2497_CR68","doi-asserted-by":"publisher","first-page":"3239","DOI":"10.1073\/pnas.1913922117","volume":"117","author":"D Wang","year":"2020","unstructured":"Wang D, Wang X, Liu P, Jing S, Du H, Zhang L et al (2020) Serotonergic afferents from the dorsal raphe decrease the excitability of pyramidal neurons in the anterior piriform cortex. Proc Natl Acad Sci U S A 117(6):3239\u201347. https:\/\/doi.org\/10.1073\/pnas.1913922117","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2497_CR69","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.neuron.2017.06.050","volume":"95","author":"JS Wiegert","year":"2017","unstructured":"Wiegert JS, Mahn M, Prigge M, Printz Y, Yizhar O (2017) Silencing neurons: tools, applications, and experimental constraints. Neuron 95(3):504\u2013529. https:\/\/doi.org\/10.1016\/j.neuron.2017.06.050","journal-title":"Neuron"},{"key":"2497_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2021.102209","volume":"209","author":"Q Yang","year":"2022","unstructured":"Yang Q, Song D, Xie Z, He G, Zhao J, Wang Z et al (2022) Optogenetic stimulation of CA3 pyramidal neurons restores synaptic deficits to improve spatial short-term memory in APP\/PS1 mice. Prog Neurobiol 209:102209. https:\/\/doi.org\/10.1016\/j.pneurobio.2021.102209","journal-title":"Prog Neurobiol"},{"issue":"1","key":"2497_CR71","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s12883-023-03191-w","volume":"23","author":"J Zhang","year":"2023","unstructured":"Zhang J, Zheng X, Zhao Z (2023) A systematic review and meta-analysis on the efficacy outcomes of selective serotonin reuptake inhibitors in depression in Alzheimer\u2019s disease. BMC Neurol 23(1):210","journal-title":"BMC Neurol"},{"key":"2497_CR72","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1646740","volume":"16","author":"Y Zheng","year":"2025","unstructured":"Zheng Y, Xu L (2025) Bidirectional crosstalk between microglia and serotonin signaling in neuroinflammation and CNS disorders. Front Immunol 16:1646740. https:\/\/doi.org\/10.3389\/fimmu.2025.1646740","journal-title":"Front Immunol"}],"container-title":["Journal of Molecular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-026-02497-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12031-026-02497-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-026-02497-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T01:43:05Z","timestamp":1774402985000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12031-026-02497-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,2]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["2497"],"URL":"https:\/\/doi.org\/10.1007\/s12031-026-02497-x","relation":{},"ISSN":["1559-1166"],"issn-type":[{"value":"1559-1166","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,2]]},"assertion":[{"value":"25 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted using ADNI data. The ADNIstudy is ethically approved and operated in accordance with the Declaration of Helsinki, 1964.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"41"}}